Dr. Gary Zweiger has spent more than 20 years in the Life Sciences and Healthcare sectors, as a Consultant, Adviser, Investor, and Business Development Executive for companies developing innovative technologies, particularly DNA sequencing and other genomics technologies (microarrays, PCR, imaging, etc.), for life science markets, such as molecular diagnostics and other genetic testing. As Co-Founder and Managing Director of BioInfleXion Point Partners LLC, he provided seed capital and management support to many innovative life sciences firms, including Cota portfolio companies: Blueprint Genetics, Mission Bio, and Purigen Biosystems. Prior to that, Dr. Zweiger held business development leadership roles at BioNano Genomics, Agilent Technologies, Applied Biosystems, and Affymetrix. Dr. Zweiger holds 7 U.S. patents and has published numerous scientific papers. He has also written a book about the race to sequence the human genome and digitize biological information, “Transducing the Genome: Information, Anarchy, and Revolution in the Biomedical Sciences”, (McGraw-Hill). He earned his B.S. in Biological Sciences, and a Ph.D. in Genetics, both from Stanford University.